FAQ Library

FAQ Library published on November 18, 2020
In this activity, Dr. Usmani describes RVD lite and where to utilize this regimen best in practice.
FAQ Library published on May 20, 2020
Join Dr. Lonial as he explains selecting treatment that may lessen immunosuppression amid the COVID-19 pandemic.
FAQ Library published on May 20, 2020
In this activity, Dr. Lonial explains how the COVID-19 pandemic is impacting clinical trial enrollment in multiple myeloma.
FAQ Library published on May 20, 2020
Join Dr. Lonial as he discusses how to continue treatment with your patients who are already immunocompromised during the COVID-19 pandemic.
FAQ Library published on May 20, 2020
In this activity, Dr. Lonial explains how the COVID-19 pandemic is impacting care delivery in his patients with multiple myeloma.
FAQ Library published on February 4, 2020
Join Dr. Ailawadhi as he discusses the racial disparities in treatment and outcomes for patients with multiple myeloma.
FAQ Library published on December 18, 2019
Join Dr. Beth Faiman as she reviews the symptoms to watch for in patients with multiple myeloma related to AL amyloidosis.
FAQ Library published on December 5, 2019
In this activity, Dr. Beth Faiman covers how to manage lenalidomide-related diarrhea in newly diagnosed patients with multiple myeloma.
FAQ Library published on November 22, 2019
In this activity, Dr. Faiman will review the results of a phase I/II study of azacitidine in combination with lenalidomide and dexamethasone in patients with RRMM.
FAQ Library published on November 14, 2019
Join Dr. Faiman as she discusses the results from evaluating the safety and efficacy of pomalidomide in the real-world setting with RRMM patients.
Page 1 of 16
Results 1 - 10 of 152